Weiler, Claudius,Duch, Thomas Adam,Haase, Marbod,Priddy, Timothy Shane,Stettler, Heike
申请号：
AU2016310535
公开号：
AU2016310535A1
申请日:
2016.08.24
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention relates to novel liquid pharmaceutical compositions comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4- cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene according to formula (I): as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.
